{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:34:38Z","timestamp":1788305678127,"version":"build-2803163510"},"reference-count":77,"publisher":"National Institute for Health and Care Research","issue":"23","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["08\/106\/02"],"award-info":[{"award-number":["08\/106\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Interferon gamma release assays (IGRAs) are blood tests recommended for the diagnosis of tuberculosis (TB) infection. There is currently uncertainty about the role and clinical utility of IGRAs in the diagnostic workup of suspected active TB in routine NHS clinical practice.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To compare the diagnostic accuracy and cost-effectiveness of T-SPOT.TB<\/jats:italic>\n \u00ae<\/jats:sup> (Oxford Immunotec, Abingdon, UK) and QuantiFERON\u00ae<\/jats:sup> TB GOLD In-Tube (Cellestis, Carnegie, VIC, Australia) for diagnosis of suspected active TB and to estimate the diagnostic accuracy of second-generation IGRAs.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Prospective within-patient comparative diagnostic accuracy study.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Secondary care.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Adults (aged \u2265\u200916 years) presenting as inpatients or outpatients at 12 NHS hospital trusts in London, Slough, Oxford, Leicester and Birmingham with suspected active TB.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n The index tests [T-SPOT.TB<\/jats:italic> and QuantiFERON GOLD In-Tube (QFT-GIT)] and new enzyme-linked immunospot assays utilising novel Mycobacterium tuberculosis<\/jats:italic> antigens (Rv3615c, Rv2654, Rv3879c and Rv3873) were verified against a composite reference standard applied by a panel of clinical experts blinded to IGRA results.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Sensitivity, specificity, predictive values and likelihood ratios were calculated to determine diagnostic accuracy. A decision tree model was developed to calculate the incremental costs and incremental health utilities [quality-adjusted life-years (QALYs)] of changing from current practice to using an IGRA as an initial rule-out test.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 363 patients had active TB (culture-confirmed and highly probable TB cases), 439 had no active TB and 43 had an indeterminate final diagnosis. Comparing T-SPOT.TB<\/jats:italic> and QFT-GIT, the sensitivities [95% confidence interval (CI)] were 82.3% (95% CI 77.7% to 85.9%) and 67.3% (95% CI 62.1% to 72.2%), respectively, whereas specificities were 82.6% (95% CI 78.6% to 86.1%) and 80.4% (95% CI 76.1% to 84.1%), respectively. T-SPOT.TB<\/jats:italic> was more sensitive than QFT-GIT (relative sensitivity 1.22, 95% CI 1.14 to 1.31; p<\/jats:italic>\u2009<\u20090.001), but the specificities were similar (relative specificity 1.02, 95% CI 0.97 to 1.08; p<\/jats:italic>\u2009=\u20090.3). For both IGRAs the sensitivity was lower and the specificity was higher for human immunodeficiency virus (HIV)-positive than for HIV-negative patients. The most promising novel antigen was Rv3615c. The added value of Rv3615c to T-SPOT.TB<\/jats:italic> was a 9% (95% CI 5% to 12%) relative increase in sensitivity at the expense of specificity, which had a relative decrease of 7% (95% CI 4% to 10%).<\/jats:p>\n The use of current IGRA tests for ruling out active TB is unlikely to be considered cost-effective if a QALY was valued at \u00a320,000 or \u00a330,000. For T-SPOT.TB<\/jats:italic>, the probability of being cost-effective for a willingness to pay of \u00a320,000\/QALY was 26% and 21%, when patients with indeterminate test results were excluded or included, respectively. In comparison, the QFT-GIT probabilities were 8% and 6%. Although the use of IGRAs is cost saving, the health detriment is large owing to delay in diagnosing active TB, leading to prolonged illness. There was substantial between-patient variation in the tests used in the diagnostic pathway.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n The recruitment target for the HIV co-infected population was not achieved.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Although T-SPOT.TB<\/jats:italic> was more sensitive than QFT-GIT for the diagnosis of active TB, the tests are insufficiently sensitive for ruling out active TB in routine clinical practice in the UK. Novel assays offer some promise.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n The novel assays require evaluation in distinct clinical settings and in immunosuppressed patient groups.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and the NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta23230","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:02:36Z","timestamp":1559116956000},"page":"1-152","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation"],"prefix":"10.3310","volume":"23","author":[{"given":"Yemisi","family":"Takwoingi","sequence":"first","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Whitworth","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Rees-Roberts","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjit","family":"Badhan","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Partlett","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Green","sequence":"additional","affiliation":[{"name":"NIHR Health Protection Research Unit in Modelling Methodology, Imperial College London, London, UK"},{"name":"Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK"},{"name":"Department of Infectious Disease Epidemiology, Imperial College London, London, UK"},{"name":"Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aime","family":"Boakye","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Lambie","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Marongiu","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[{"name":"Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"White","sequence":"additional","affiliation":[{"name":"NIHR Health Protection Research Unit in Modelling Methodology, Imperial College London, London, UK"},{"name":"Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK"},{"name":"Department of Infectious Disease Epidemiology, Imperial College London, London, UK"},{"name":"Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Deeks","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onn Min","family":"Kon","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK"},{"name":"St Mary\u2019s Hospital, Imperial College Healthcare Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Lalvani","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2019,5]]},"reference":[{"key":"key20190524112039644_ref1-bib1","volume-title":"Global Tuberculosis Report 2015","author":"World Health Organization","year":"2015","edition":"20th edn."},{"key":"key20190524112039644_ref1-bib2","volume-title":"Tuberculosis in England 2015. Report Version 1.1","author":"Public Health England","year":"2015"},{"key":"key20190524112039644_ref1-bib3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/0003-4819-148-5-200803040-00003","article-title":"Improved diagnostic evaluation of suspected tuberculosis","volume":"148","author":"Dosanjh","year":"2008","journal-title":"Ann Intern Med"},{"key":"key20190524112039644_ref1-bib4","volume-title":"Tuberculosis in the UK: Annual Report on Tuberculosis Surveillance in the UK 2008","author":"Health Protection Agency Centre for Infections","year":"2008"},{"key":"key20190524112039644_ref1-bib5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"key20190524112039644_ref1-bib6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ymeth.2012.12.012","article-title":"IGRAs \u2013 the gateway to T cell based TB diagnosis","volume":"61","author":"Whitworth","year":"2013","journal-title":"Methods"},{"key":"key20190524112039644_ref1-bib7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"key20190524112039644_ref1-bib8","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"key20190524112039644_ref1-bib9","volume-title":"T-SPOT.TB Package Insert","author":"Oxford Immunotec"},{"key":"key20190524112039644_ref1-bib10","volume-title":"QuantiFERON TB Gold (QFT). ELISA Package Insert","author":"Qiagen","year":"2009"},{"key":"key20190524112039644_ref1-bib11","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control","author":"NICE","year":"2011"},{"key":"key20190524112039644_ref1-bib12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/thorax.57.9.804","article-title":"A meta-analysis of the effect of Bacille Calmette Gu\u00e9rin vaccination on tuberculin skin test measurements","volume":"57","author":"Wang","year":"2002","journal-title":"Thorax"},{"key":"key20190524112039644_ref1-bib13","doi-asserted-by":"publisher","first-page":"e3417","DOI":"10.1371\/journal.pone.0003417","article-title":"Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study","volume":"3","author":"Goletti","year":"2008","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/sim.1058","article-title":"Sample size calculations for comparative studies of medical tests for detecting presence of disease","volume":"21","author":"Alonzo","year":"2002","journal-title":"Stat Med"},{"key":"key20190524112039644_ref1-bib15","doi-asserted-by":"publisher","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/QAD.0b013e32835e2cb1","article-title":"Decreasing incidence of tuberculosis among heterosexuals living with diagnosed HIV in England and Wales","volume":"27","author":"Rice","year":"2013","journal-title":"AIDS"},{"key":"key20190524112039644_ref1-bib17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"key":"key20190524112039644_ref1-bib18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval Estimation for a Binomial Proportion","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci"},{"key":"key20190524112039644_ref1-bib19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0895-4356(91)90128-V","article-title":"Likelihood ratios with confidence: sample size estimation for diagnostic test studies","volume":"44","author":"Simel","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"key20190524112039644_ref1-bib20","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/(SICI)1097-0258(19970615)16:11<1263::AID-SIM550>3.0.CO;2-M","article-title":"A marginal regression modelling framework for evaluating medical diagnostic tests","volume":"16","author":"Leisenring","year":"1997","journal-title":"Stat Med"},{"key":"key20190524112039644_ref1-bib21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5588\/ijtld.13.0694","article-title":"Smoking increases risk of recurrence after successful anti-tuberculosis treatment: a population-based study","volume":"18","author":"Yen","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20190524112039644_ref1-bib22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jclinepi.2007.02.012","article-title":"Three methods to construct predictive models using logistic regression and likelihood ratios to facilitate adjustment for pretest probability give similar results","volume":"61","author":"Chan","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"key20190524112039644_ref1-bib23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0272989X9201200202","article-title":"Application of logistic regression to the analysis of diagnostic data: exact modeling of a probability tree of multiple binary variables","volume":"12","author":"Knottnerus","year":"1992","journal-title":"Med Decis Making"},{"key":"key20190524112039644_ref1-bib24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","journal-title":"Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA"},{"key":"key20190524112039644_ref1-bib25","volume-title":"Data Protection Act 1998","author":"Great Britain","year":"1998"},{"key":"key20190524112039644_ref1-bib26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/thorax.56.3.173","article-title":"Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998","volume":"56","author":"Rose","year":"2001","journal-title":"Thorax"},{"key":"key20190524112039644_ref1-bib27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1473-3099(18)30613-3","article-title":"Clinical utility of existing and second-generation interferon-\u03b3 release-assays for diagnostic evaluation of tuberculosis: an observational cohort study","volume":"19","author":"Whitworth","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key20190524112039644_ref1-bib28","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1128\/JCM.00823-15","article-title":"Interferon gamma release assays for diagnosis of pleural tuberculosis: a systematic review and meta-analysis","volume":"53","author":"Aggarwal","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key20190524112039644_ref1-bib29","doi-asserted-by":"publisher","first-page":"e107245","DOI":"10.1371\/journal.pone.0107245","article-title":"Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\u00f4te d\u2019Ivoire, West Africa","volume":"9","author":"Danel","year":"2014","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib30","doi-asserted-by":"publisher","first-page":"e73579","DOI":"10.1371\/journal.pone.0073579","article-title":"A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis","volume":"8","author":"Lagrange","year":"2013","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib31","first-page":"153","article-title":"Interferon-\u03b3 release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response","volume":"37","author":"Sauzullo","year":"2014","journal-title":"New Microbiol"},{"key":"key20190524112039644_ref1-bib32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jval.2013.02.010","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"key20190524112039644_ref1-bib33","first-page":"296","article-title":"Health status of UK patients with active tuberculosis","volume":"14","author":"Kruijshaar","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20190524112039644_ref1-bib34","volume-title":"UK Population Norms for EQ-5D. Discussion Paper 172","author":"Kind","year":"1999"},{"key":"key20190524112039644_ref1-bib35","volume-title":"National Tariff Payment System 2014\/15","author":"Monitor and NHS England","year":"2013"},{"key":"key20190524112039644_ref1-bib36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.rmed.2011.10.005","article-title":"The cost effectiveness of nucleic acid amplification techniques for the diagnosis of tuberculosis","volume":"106","author":"Hughes","year":"2012","journal-title":"Respir Med"},{"key":"key20190524112039644_ref1-bib37","volume-title":"Unit Costs of Health & Social Care","author":"Curtis","year":"2015"},{"issue":"34","key":"key20190524112039644_ref1-bib38","doi-asserted-by":"publisher","DOI":"10.3310\/hta19340","article-title":"Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis","volume":"19","author":"Drobniewski","year":"2015","journal-title":"Health Technol Assess"},{"key":"key20190524112039644_ref1-bib39","volume-title":"Tuberculosis: Prevention, Diagnosis, Management and Service Organisation. NICE Guideline 33","author":"NICE","year":"2016"},{"key":"key20190524112039644_ref1-bib40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3310\/hta20380","article-title":"Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation","volume":"20","author":"Auguste","year":"2016","journal-title":"Health Technol Assess"},{"key":"key20190524112039644_ref1-bib41","first-page":"1","volume-title":"Accurate Diagnosis of Latent Tuberculosis in Children, in People Who are Immunocompromised or at Risk from Immunosuppression, and Recent Arrivals from Countries with a High Incidence of Tuberculosis: Systematic Review and Economic Evaluation. Appendix H: Warwick Evidence Diagnosis of LTBI","author":"Auguste","year":"2016"},{"key":"key20190524112039644_ref1-bib42","first-page":"1","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. NICE Guideline. Update of CG117 \u2013 Appendix 6. Cost Effectiveness Analysis of Interferon Gamma Release Assay (IGRA) Testing for Latent Tuberculosis","author":"NICE","year":"2010"},{"key":"key20190524112039644_ref1-bib43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon \u03b3 release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek","year":"2013","journal-title":"Thorax"},{"key":"key20190524112039644_ref1-bib44","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis and Measures for its Prevention and Control. NICE Guideline 33","author":"NICE","year":"2006"},{"key":"key20190524112039644_ref1-bib45","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2016","edition":"69 edn."},{"key":"key20190524112039644_ref1-bib46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"key20190524112039644_ref1-bib47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/00365548.2014.885657","article-title":"Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls","volume":"46","author":"Faurholt-Jepsen","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"key20190524112039644_ref1-bib48","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1183\/13993003.02033-2015","article-title":"First independent evaluation of QuantiFERON-TB Plus performance","volume":"47","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"key20190524112039644_ref1-bib49","volume-title":"Human Tissue Act 2004","author":"Great Britain","year":"2004"},{"key":"key20190524112039644_ref1-bib50","first-page":"180","article-title":"Diagnostic utility of QuantiFERON-TB gold in-tube in active pulmonary tuberculosis in Nigeria","volume":"32","author":"Adewole","year":"2013","journal-title":"West Afr J Med"},{"key":"key20190524112039644_ref1-bib51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jinf.2013.06.005","article-title":"Factors influencing discordant results of the QuantiFERON-TB Gold In-tube test in patients with active TB","volume":"67","author":"Jeon","year":"2013","journal-title":"J Infect"},{"key":"key20190524112039644_ref1-bib52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.diagmicrobio.2013.03.030","article-title":"Evaluation of interferon-\u03b3 release assay in the diagnosis of osteoarticular tuberculosis","volume":"76","author":"Jia","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key20190524112039644_ref1-bib53","first-page":"633","article-title":"Comparison of sensitivity of QuantiFERON-TB gold test and tuberculin skin test in active pulmonary tuberculosis","volume":"23","author":"Khalil","year":"2013","journal-title":"J Coll Physicians Surg Pak"},{"key":"key20190524112039644_ref1-bib54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4111\/kju.2013.54.2.123","article-title":"Feasibility of the interferon-\u03b3 release assay for the diagnosis of genitourinary tuberculosis in an endemic area","volume":"54","author":"Kim","year":"2013","journal-title":"Korean J Urol"},{"key":"key20190524112039644_ref1-bib55","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/1469-0691.12129","article-title":"Interferon-\u03b3 release assays in the diagnosis of active tuberculosis disease in a low-incident setting: a 5-year review of data","volume":"19","author":"Lavender","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key20190524112039644_ref1-bib56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1751-2980.12017","article-title":"Utility of in vitro interferon-\u03b3 release assay in differential diagnosis between intestinal tuberculosis and Crohn\u2019s disease","volume":"14","author":"Lei","year":"2013","journal-title":"J Dig Dis"},{"key":"key20190524112039644_ref1-bib57","doi-asserted-by":"publisher","first-page":"e83857","DOI":"10.1371\/journal.pone.0083857","article-title":"Interferon-gamma release assay performance of pleural fluid and peripheral blood in pleural tuberculosis","volume":"8","author":"Liu","year":"2013","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib58","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.5588\/ijtld.13.0348","article-title":"Role of the QuantiFERON\u00ae-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis","volume":"17","author":"Lodha","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20190524112039644_ref1-bib59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tube.2013.02.007","article-title":"Screening for TB in high school adolescents in a high burden setting in South Africa","volume":"93","author":"Mahomed","year":"2013","journal-title":"Tuberculosis"},{"key":"key20190524112039644_ref1-bib60","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/00016489.2013.850174","article-title":"Interferon-\u03b3 release assay in the diagnosis of laryngeal tuberculosis","volume":"134","author":"Fei","year":"2014","journal-title":"Acta Otolaryngol"},{"key":"key20190524112039644_ref1-bib61","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1097\/INF.0000000000000353","article-title":"Performance of interferon-gamma release assay for the diagnosis of active or latent tuberculosis in children in the first 2 years of age: a multicenter study of the Italian Society of Pediatric Infectious Diseases","volume":"33","author":"Garazzino","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key20190524112039644_ref1-bib62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4046\/trd.2014.76.1.23","article-title":"Interferon-\u03b3 enzyme-linked immunospot assay in patients with tuberculosis and healthy adults","volume":"76","author":"Kim","year":"2014","journal-title":"Tuberc Respir Dis"},{"key":"key20190524112039644_ref1-bib63","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/cid\/ciu045","article-title":"Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis","volume":"58","author":"Kim","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key20190524112039644_ref1-bib64","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3349\/ymj.2014.55.3.725","article-title":"Whole blood interferon-\u03b3 release assay is insufficient for the diagnosis of sputum smear negative pulmonary tuberculosis","volume":"55","author":"Park","year":"2014","journal-title":"Yonsei Med J"},{"key":"key20190524112039644_ref1-bib65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00431-013-2161-x","article-title":"The sensitivity of an interferon-\u03b3 release assay in microbiologically confirmed pediatric tuberculosis","volume":"173","author":"Schopfer","year":"2014","journal-title":"Eur J Pediatr"},{"key":"key20190524112039644_ref1-bib66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/15513815.2013.878010","article-title":"The sensitivity of T-SPOT.TB assay in diagnosis of pediatric tuberculosis","volume":"33","author":"Wang","year":"2014","journal-title":"Fetal Pediatr Pathol"},{"key":"key20190524112039644_ref1-bib67","doi-asserted-by":"publisher","first-page":"e107208","DOI":"10.1371\/journal.pone.0107208","article-title":"Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis","volume":"9","author":"Wlodarczyk","year":"2014","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/0974-777X.162231","article-title":"Diagnostic utility of QuantiFERON-TB Gold (QFT-G) in active pulmonary tuberculosis","volume":"7","author":"Anwar","year":"2015","journal-title":"J Glob Infect Dis"},{"key":"key20190524112039644_ref1-bib69","doi-asserted-by":"publisher","first-page":"e0103763","DOI":"10.1371\/journal.pone.0103763","article-title":"Fluctuating behavior and influential factors in the performance of the QuantiFERON-TB Gold In-Tube Assay in the diagnosis of tuberculosis","volume":"10","author":"Bao","year":"2015","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib70","doi-asserted-by":"publisher","first-page":"e0138952","DOI":"10.1371\/journal.pone.0138952","article-title":"Accuracy of QuantiFERON-TB gold test for tuberculosis diagnosis in children","volume":"10","author":"Sali","year":"2015","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.diagmicrobio.2015.02.002","article-title":"Diagnostic utility of interferon-gamma release assay in extrapulmonary tuberculosis","volume":"82","author":"Shin","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key20190524112039644_ref1-bib72","doi-asserted-by":"publisher","first-page":"e0143820","DOI":"10.1371\/journal.pone.0143820","article-title":"Performance of the interferon gamma release assays in tuberculosis disease in children five years old or less","volume":"10","author":"Sun","year":"2015","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib73","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jmii.2015.07.012","article-title":"Diagnostic utility of QuantiFERON-TB Gold In-Tube test in pediatric tuberculosis disease in Taiwanese children","volume":"50","author":"Wong","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"key20190524112039644_ref1-bib74","doi-asserted-by":"publisher","first-page":"e0121021","DOI":"10.1371\/journal.pone.0121021","article-title":"Diagnostic values of the QuantiFERON-TB Gold In-tube assay carried out in China for diagnosing pulmonary tuberculosis","volume":"10","author":"Xia","year":"2015","journal-title":"PLOS ONE"},{"key":"key20190524112039644_ref1-bib75","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/ped.12659","article-title":"Comparison of tuberculin skin test and QuantiFERON\u00ae-TB Gold In-Tube for the diagnosis of childhood tuberculosis","volume":"57","author":"Uzunhan","year":"2015","journal-title":"Pediatr Int"},{"key":"key20190524112039644_ref1-bib76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijid.2016.01.004","article-title":"Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis","volume":"44","author":"Azghay","year":"2016","journal-title":"Int J Infect Dis"},{"key":"key20190524112039644_ref1-bib77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.diagmicrobio.2016.02.001","article-title":"Diagnostic performance of interferon-\u03b3 release assay for lymph node tuberculosis","volume":"85","author":"Jia","year":"2016","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta23230\/hta23230.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2003464","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta23230\/hta23230.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2029245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:40:40Z","timestamp":1692114040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta23230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":77,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["10.3310\/hta23230"],"URL":"https:\/\/doi.org\/10.3310\/hta23230","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}